Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe)

NCT04942730 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Acute Lymphoblastic
Myeloid Leukemia, Acute
Biphenotypic Acute Leukemia
Lymphoblastic Lymphoma
Myelodysplastic Syndromes
Myeloproliferative Neoplasm

Interventions

DRUG: Fludarabine
DRUG: Bendamustine Hydrochloride
DRUG: Busulfan
DRUG: Cyclophosphamide
DRUG: Mycophenolate Mofetil
DRUG: Tacrolimus 5Mg Cap

Sponsor

St. Petersburg State Pavlov Medical University